Researchers have discovered and validated a blood test that can predict with greater than 90 percent accuracy if a healthy person will develop mild cognitive impairment or Alzheimer’s disease within three years. It is the first known published report of blood-based biomarkers for preclinical Alzheimer’s disease.
A team of University of Notre Dame researchers discovered a new class of antibiotics to fight...
For the first time, researchers have shown that an essential biological process known as protein...
Researchers at the UNC School of Medicine have devised a new biochemical technique that will...
ViroStat has released a broadly reactive monoclonal antibody that reacts with many Enteroviruses. This new pan-reactive monoclonal antibody is positive for all 27 Enteroviruses tested to-date. ViroStat has also released specific monoclonal antibodies to EV70 (conjunctivitis) and EV71 (hand, foot and mouth disease).
An international team of researchers led by scientists at The Wistar Institute have discovered and defined LIMD2, a protein that can drive metastasis, the process where tumors spread throughout the body. Their study defines the structure of LIMD2 and correlates the protein in metastatic bladder, melanoma, breast, and thyroid tumors.
Alzheimer’s Research Team Employs Stem Cells to Understand Disease Processes and Study New TreatmentsMarch 10, 2014 12:53 pm | News | Comments
A team of Alzheimer’s disease (AD) researchers at Brigham and Women’s Hospital has been able to study the underlying causes of AD and develop assays to test newer approaches to treatment by using stem cells derived from related family members with a genetic predisposition to AD.
UT Arlington biochemists say their newly published study brings researchers a step closer to understanding how the commonly used synthetic compound bisphenol-A (BPA) may promote breast cancer growth. The researchers found that when breast cancer and mammary gland cells were exposed to BPA in lab tests, the BPA worked together with naturally present molecules, including estrogen, to create abnormal amounts of HOTAIR expression.
A small filter the size of a contact lens could possibly make life easier for some of the estimated 500 million people worldwide who suffer from itching, sneezing, and a runny nose as soon as the pollen season starts. A clinical study from Aarhus University concludes that a newly developed Danish mini-filter—Rhinix—appears to be significantly more effective against the discomfort of seasonal hay fever than a filterless placebo.
At first, Ashok Yadav ignored the patches of pink skin on his arm. But when pale sores erupted on his body and he lost sensation in his fingertips, a doctor issued the devastating diagnosis: Yadav had leprosy. "What followed was like a nightmare," said Yadav, who has lived in Kasturba Gram, a...
Biomarkers for bone formation and resorption predict outcomes for men with castration-resistant prostate cancer, a team of researchers have found. Their study also found that the markers identified a small group of patients who responded to the investigational drug atrasentan. The markers’ predictive ability could help clinicians match treatments with individual patients, track their effectiveness and affect clinical trial design.
Beckman Coulter Life Sciences received 510(k) clearance from the U.S. Food and Drug Administration and an Import Medical Device Registration Certificate from the China Food and Drug Administration for the in vitro diagnostic use of the Navios flow cytometry system.
The progression of Alzheimer’s may slow once symptoms appear and do significant damage, according to a study investigating an inherited form of the disease. Professor Colin Masters from the Florey Institute of Neuroscience and Mental Health and University of Melbourne—and colleagues in the UK and US—have found rapid neuronal damage begins 10 to 20 years before symptoms appear.
The majority of pediatric Clostridium difficile infections, which are bacterial infections that cause severe diarrhea and are potentially life-threatening, occur among children in the general community who recently took antibiotics prescribed in doctor’s offices for other conditions, according to a new study by the Centers for Disease Control and Prevention.
Seemingly healthy cells may hide clues that lung cancer will later develop, according to a study led by researchers at The University of Texas MD Anderson Cancer Center. Examination of gene expression in patients with non-small cell lung cancer showed the area adjacent to tumors is rich with cancer markers. In addition, researchers discovered the previously unknown role of a cancer-promoting gene in the airways of smokers with lung cancer.
Breast cancer patients with high levels of vitamin D in their blood are twice as likely to survive the disease as women with low levels of this nutrient. Previous studies showed that low vitamin D levels were linked to a high risk of premenopausal breast cancer. That finding prompted research that questioned the relationship between 25-hydroxyvitamin D and breast cancer survival rates.
Using technologies and computational modeling that trace the destiny of single cells, researchers at the University of California, San Diego School of Medicine describe for the first time the earliest stages of fate determination among white blood cells called T lymphocytes, providing new insights that may help drug developers create more effective, longer-lasting vaccines against microbial pathogens or cancer.
The uplifting effects of energy drinks are well advertised, but a new report finds consumption among teenagers may be linked with poor mental health and substance use. Researchers are calling for limits on teen’s access to the drinks and reduction in the amount of the caffeine in each can.
The Oregon Legislature moved late Thursday to give Oregon Health & Science University all of the $200 million it requested for cancer research facilities. The OHSU money was included in six budget bills approved in a Ways and Means subcommittee as lawmakers raced to adjourn the five-week legislative session on Friday.